NCT00006208UnknownPhase 3
A Randomized, Double-Blind, Equivalence Trial Comparing Emtricitabine to Stavudine Within a Triple Drug Combination Containing Didanosine Plus Efavirenz in Antiretroviral-Drug Naive HIV-1 Infected Patients
Conditions
Drugs
Trial Snapshot
- Phase
- Phase 3
- Sponsor
- Triangle Pharmaceuticals
- Locations
- 111
Study Overview
Brief Summary
The purpose of this study is to compare the safety and effectiveness of emtricitabine and stavudine when given with didanosine plus efavirenz to HIV-infected patients.
Study Design
- Study Type
- Interventional
- Primary Purpose
- Treatment
- Masking
- Double
Eligibility Criteria
- Ages
- 18 Years to — (Adult, Older Adult)
- Sex
- All
- Accepts Healthy Volunteers
- No
Inclusion Criteria
- Not provided
Exclusion Criteria
- Not provided
Investigators
Study Sites (111)
Loading locations...
Similar Trials
Completed
Phase 3
Telbivudine Versus Lamivudine in Adults With Decompensated Chronic Hepatitis B and Evidence of CirrhosisHepatitis B, ChronicHepatitisCirrhosisNCT00076336Novartis Pharmaceuticals232
Completed
Phase 3
Study to Evaluate Switching From a Regimen Consisting of Efavirenz/Emtricitabine/Tenofovir Disoproxil Fumarate (EFV/FTC/TDF) Fixed Dose Combination (FDC) to Emtricitabine/Rilpivirine/Tenofovir Alafenamide (FTC/RPV/TAF) FDC in Virologically-Suppressed, HIV-1 Infected AdultsHIV-1 InfectionNCT02345226Gilead Sciences881
Completed
Phase 3
A Study of Two Approved Drugs in the Treatment of Postoperative Dental Pain (0966-190)(COMPLETED)Postoperative PainNCT00092339Merck Sharp & Dohme LLC125
Completed
Not Applicable
A Randomized, Double-Blind, Trial Comparing Epinephrine Versus Phenylephrine as a Vasoconstrictor in Regional Anesthesia for Upper Extremity SurgeryHealthyNCT00225043New York Presbyterian Brooklyn Methodist Hospital60
Terminated
Phase 3
TAF/FTC for Pre-exposure Prophylaxis of COVID-19 in Healthcare Workers (CoviPrep Study)Healthcare WorkersCOVID-19SARS-CoV 2NCT04405271Hospital Italiano de Buenos Aires1,378